02/05/2014
no comments
0
0
US drugs giant Pfizer has raised the price it is offering for the UK’s AstraZeneca to £50 a share, valuing the firm at £63bn.
BBC News – Business
You May Also Be Interested In:
- Wegovy: Weight-loss drug firm becomes Europe's most valuable by Craig Taylor
- US car giant agrees pay deal to end strike by Craig Taylor
- Energy price cap to fall but bills will stay high by Craig Taylor
- Buyer of battery firm Britishvolt fails to pay staff by Craig Taylor
- Energy price cap will rise in January adding pressure on… by Craig Taylor
- DP World in Tanzania: The UAE firm taking over Africa's… by Craig Taylor
0
0
